Source link : https://newshealth.biz/health-news/ribociclib-shows-lasting-benefit-in-early-breast-cancer/
Researchers examined invasive disease-free survival rates at 4 years in a randomized phase 3 trial of adjuvant treatment for women and men with HR+/ERBB2-negative early breast cancer. Medscape Medical News Source link : https://www.medscape.com/viewarticle/ribociclib-shows-lasting-benefit-early-breast-cancer-2025a1000pol?src=rss Author : Publish date : 2025-09-25 15:05:00 Copyright for syndicated content belongs to the linked Source.
The post Ribociclib Shows Lasting Benefit in Early Breast Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-09-25 15:05:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8